VAV1 anticorps (Vav 1 Oncogene) (Tyr174)

Details for Product anti-VAV1 Antibody No. ABIN2687860
Antigène
  • VAV
  • Vav
  • vav-T
  • vav guanine nucleotide exchange factor 1
  • vav 1 oncogene
  • vav guanine nucleotide exchange factor 1 L homeolog
  • VAV1
  • Vav1
  • vav1.L
Épitope
Tyr174
40
17
16
9
9
7
7
6
4
3
3
3
2
2
2
2
2
2
1
1
1
1
1
1
1
1
1
Reactivité
Humain, Souris
155
85
68
3
3
2
1
1
1
1
Hôte
Lapin
143
13
Clonalité
Monoclonal
Conjugué
Cet anticorp VAV1 est non-conjugé
6
4
4
4
4
4
4
2
2
2
2
2
Application
Western Blotting (WB)
124
73
32
12
10
10
5
3
1
1
Options
Immunogène The antiserum was produced against synthesized non-phosphopeptide derived from human Vav around the phosphorylation site of tyrosine 174 (E-I-YP-E-D).
Specificité Vav (Ab-174) antibody detects endogenous levels of total Vav protein.
Purification The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen.
Plasmids, Primers & others Plasmids, Primers & others VAV1 products on genomics-online (e.g. as negative or positive controls)
Antigène
Autre désignation VAV (VAV1 Antibody Extrait)
Pathways TCR Signaling, Fc-epsilon Receptor Signaling Pathway, EGFR Signaling Pathway, Neurotrophin Signaling Pathway, CXCR4-mediated Signaling Events
Indications d'application WB: 1:500~1:1000
Restrictions For Research Use only
Format Liquid
Concentration 1 μg/μL
Buffer phosphate buffered saline (without Mg2+ and Ca2+), pH 7.4, 150 mM NaCl, 0.02 % sodium azide and 50 % glycerol.
Agent conservateur Sodium azide
Précaution d'utilisation This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
Stock 4 °C,-20 °C
Avez-vous cherché autre chose?